CSNK1A1 and prostate neoplasm: Therefore, if these changes result in CK1 regulatory dysfunction, the ability of CK1 to negatively regulate YAP activity will be impaired, leading to increased downstream transcriptional activity and contributing to increased migration of prostate tumour cells.